Clinical trial approved for new cancer treatment
The Swedish Medical Products Agency and the Regional Ethics Committee has approved the initiation of a clinical trial for a completely new form of neuroendocrine cancer treatment that uses an oncolytic virus. The virus owes its development to donations from thousands of people all over the world.
The researchers behind the virus are professor Magnus Essand and researcher Justyna Leja, both of the Department of Immunology, Genetics and Pathology, Uppsala University, as well as Kjell Öberg, emeritus professor of endocrine oncology at the Department of Medical Sciences, Uppsala University.
More information: http://www.uu.se/en/support/oncolytic/
The researchers behind the virus are professor Magnus Essand and researcher Justyna Leja, both of the Department of Immunology, Genetics and Pathology, Uppsala University, as well as Kjell Öberg, emeritus professor of endocrine oncology at the Department of Medical Sciences, Uppsala University.
More information: http://www.uu.se/en/support/oncolytic/
Titta först på filmen och testa sedan dina kunskaper med detta självrättande test.
Använd koden nedan för att visa denna film på en annan webbsida, till exempel Studentportalen.
Kontaktperson
Gunilla Sthyr, Enheten för press och redaktion
Uppdaterad
25 februari 2016
Längd
00:01:36
Visningar
2325
För att lägga till denna film till en kanal måste du vara inloggad och ha skapat en kanal.